Overexpression and deregulation of c-Myb functions have been also frequently observed in hematopoietic tumors, especially in AML, ALL, and lymphomas, and the implications of c-Myb overexpression/deregulation and leukemogenesis have been extensively investigated38–41. The gene discussed is MYB; the disease is lymphoma.